Clinical Trials Logo

Clinical Trial Summary

The study schema is shown in Figure 4. (A) All patients referred to one of the participating academic centers for EUS evaluation of the PCL will be enrolled in the protocol if they satisfy inclusion criteria. Patient consent will be obtained during the clinic visit or prior to their EUS. EUS-guided nCLE imaging is first performed (B) followed by EUS-guided FNA and aspiration of cyst fluid. The cyst fluid is analyzed for CEA and cytology. As per institutional standard of care, the cyst fluid is also sent for molecular analysis. The results of the cyst fluid molecular analysis (B) will be utilized for the most likely diagnosis. Based on institutional multidisciplinary tumor board meetings, surgery is performed as indicated (C). Surgical histopathology serves as "gold standard" for diagnosis. It is anticipated that the majority of patients will undergo surgical resection after their EUS.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03492151
Study type Observational
Source Ohio State University
Contact Megan Fry
Phone 614-293-1056
Email Megan.Fry@osumc.edu
Status Recruiting
Phase
Start date October 1, 2018
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05572788 - Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts N/A
Completed NCT01770405 - Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract N/A
Completed NCT01643460 - Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts N/A
Recruiting NCT03260842 - Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Recruiting NCT04291651 - UCSF PANC Cyst Registry
Recruiting NCT05692596 - The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Recruiting NCT03334708 - A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Recruiting NCT04140435 - EUS-guided Through-the-needle Microforceps Biopsy Outcomes
Terminated NCT00550108 - Management of Incidentally Discovered Pancreatic Cysts Phase 3
Completed NCT03169842 - Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts N/A
Not yet recruiting NCT06320990 - Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection Phase 1
Recruiting NCT04404101 - Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies N/A
Recruiting NCT06305728 - A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting NCT06340620 - EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope N/A
Recruiting NCT02343692 - A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas N/A
Recruiting NCT02775461 - Pancreas Registry and High Risk Registry
Active, not recruiting NCT01563133 - Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas N/A
Completed NCT00222898 - Cancer Detection in Pancreatic Cysts N/A
Completed NCT03740360 - Contrast Enhanced Ultrasound and Molecular Analysis in the Diagnosis of Pancreatic Cyst
Recruiting NCT02422147 - EUS-guided Ablation of Pancreatic Cyst Neoplasms